Efficacy and safety of a lidocaine/tetracaine medicated patch or peel for dermatologic procedures: a meta-analysis

Won Oak Kim, Byung Min Song, Hae Keum Kil, Won Oak Kim, Byung Min Song, Hae Keum Kil

Abstract

Background: To justify the use of the lidocaine/tetracaine medicated patch or peel as a preventive treatment for reducing pain and discomfort in adults and children. We reviewed randomized controlled trials (RCTs) to evaluate the efficacy and safety of the lidocaine/tetracaine medicated patch or peel compared with placebo.

Methods: Ten RCTs (574 patients) were included in this systemic review. Relevant studies were identified through searches of MEDLINE, SCOPUS and the Cochrane database library. The outcome was the adequacy of cutaneous anesthesia reflected in the patient's assessment of pain intensity during minor dermatologic procedures and adverse effects after application of the lidocaine/tetracaine medicated patch or peel versus placebo.

Results: The efficacy of the lidocaine/tetracaine patch or peel was consistently very significantly beneficial 30 or 60 minutes after the application compared to placebo (Relative risk, RR: 2.5; Number needed to treat, NNT: 2.2). We did not identify any difference in the effectiveness of adequate analgesia between the lidocaine/tetracaine patch and peel (the number needed to treat or to harm, NNT 2.4 vs. 2.0). No serious side effects or adverse events were observed with the lidocaine/tetracaine medicated patch or peel and placebo. Minor skin reactions were transient and resolved without treatment (Odd ratio, OR: 1.4 and 95% confidence interval, CI: 0.9-2.1; NNT: 14.9).

Conclusions: The lidocaine/tetracaine medicated patch or peel is a well accepted, effective and safe method for minor dermatologic procedures based on pooled data of trials in terms of adequacy of cutaneous anesthesia and adverse effects.

Keywords: Lidocaine; Meta-analysis; Tetracaine; Topical anesthetics.

Figures

Fig. 1
Fig. 1
An annotated forest plot (adequacy of cutaneous anesthesia) shows individual trials, depicted as filled squares, with the relative size of weights and horizontal bars as the confidence interval. The bottom diamond shape refers to the pooled value. RR: relative risk.
Fig. 2
Fig. 2
An annotated forest plot (adverse effects) shows individual trials, depicted as filled squares, with the relative size of weights and horizontal bars as the confidence interval. The bottom diamond shape refers to the pooled value. OR: odd ratio.

References

    1. Eidelman A, Weiss JM, Lau J, Carr DB. Topical anesthetics for dermal instrumentation: a systematic review of randomized, controlled trials. Ann Emerg Med. 2005;46:343–351.
    1. Chen BK, Cunningham BB. Topical anesthetics in children: agents and techniques that equally comfort patients, parents, and clinicians. Curr Opin Pediatr. 2001;13:324–330.
    1. Croxtall JD. Lidocaine/tetracaine medicated plaster: in minor dermatological and needle puncture procedures. Drugs. 2010;70:2113–2120.
    1. Shainhouse T, Cunningham BB. Topical anesthetics: physiology, formulations, and novel delivery systems. Am J Drug Deliv. 2004;2:89–99.
    1. Tadicherla S, Berman B. Percutaneous dermal drug delivery for local pain control. Ther Clin Risk Manag. 2006;2:99–113.
    1. Friedman PM, Mafong EA, Friedman ES, Geronemus RG. Topical anesthetics update: EMLA and beyond. Dermatol Surg. 2001;27:1019–1026.
    1. Shomaker TS, Zhang J, Love G, Basta S, Ashburn MA. Evaluating skin anesthesia after administration of a local anesthetic system consisting of an S-Caine patch and a controlled heat-aided drug delivery (CHADD) patch in volunteers. Clin J Pain. 2000;16:200–204.
    1. Alster TS. The lidocaine/tetracaine peel: a novel topical anesthetic for dermatologic procedures in adult patients. Dermatol Surg. 2007;33:1073–1081.
    1. Kaweski S. Topical anesthetic creams. Plast Reconstr Surg. 2008;121:2161–2165.
    1. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
    1. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50.
    1. Bax L, Yu LM, Ikeda N, Moons KG. A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol. 2007;7:40.
    1. Bryan HA, Alster TS. The S-Caine peel: a novel topical anesthetic for cutaneous laser surgery. Dermatol Surg. 2002;28:999–1003.
    1. Alster TS, Lupton JR. Evaluation of a novel topical anesthetic agent for cutaneous laser resurfacing: a randomized comparison study. Dermatol Surg. 2002;28:1004–1006.
    1. Chen JZ, Alexiades-Armenakas MR, Bernstein LJ, Jacobson LG, Friedman PM, Geronemus RG. Two randomized, double-blind, placebo-controlled studies evaluating the S-Caine Peel for induction of local anesthesia before long-pulsed Nd:YAG laser therapy for leg veins. Dermatol Surg. 2003;29:1012–1018.
    1. Doshi SN, Friedman PM, Marquez DK, Goldberg LH. Thirty-minute application of the S-Caine peel prior to nonablative laser treatment. Dermatol Surg. 2003;29:1008–1011.
    1. Jih MH, Friedman PM, Sadick N, Marquez DK, Kimyai-Asadi A, Goldberg LH. 60-minute application of S-Caine Peel prior to 1,064 nm long-pulsed Nd:YAG laser treatment of leg veins. Lasers Surg Med. 2004;34:446–450.
    1. Sethna NF, Verghese ST, Hannallah RS, Solodiuk JC, Zurakowski D, Berde CB. A randomized controlled trial to evaluate S-Caine patch for reducing pain associated with vascular access in children. Anesthesiology. 2005;102:403–408.
    1. Chen JZ, Jacobson LG, Bakus AD, Garden JM, Yaghmai D, Bernstein LJ, et al. Evaluation of the S-Caine Peel for induction of local anesthesia for laser-assisted tattoo removal: randomized, double-blind, placebo-controlled, multicenter study. Dermatol Surg. 2005;31:281–286.
    1. Schecter AK, Pariser DM, Pariser RJ, Ling MR, Stewart D, Sadick NS. Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients. Dermatol Surg. 2005;31:287–291.
    1. Berman B, Flores J, Pariser D, Pariser R, de Araujo T, Ramirez CC. Self-warming lidocaine/tetracaine patch effectively and safely induces local anesthesia during minor dermatologic procedures. Dermatol Surg. 2005;31:135–138.
    1. Curry SE, Finkel JC. Use of the Synera patch for local anesthesia before vascular access procedures: a randomized, double-blind, placebo-controlled study. Pain Med. 2007;8:497–502.
    1. Singer AJ, Taira BR, Chisena EN, Gupta N, Chipley J. Warm lidocaine/tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial. Ann Emerg Med. 2008;52:41–47.
    1. George RB, Habib AS, Allen TK, Muir HA. Brief report: a randomized controlled trial of Synera versus lidocaine for epidural needle insertion in labouring parturients. Can J Anaesth. 2008;55:168–171.
    1. Sawyer J, Febbraro S, Masud S, Ashburn MA, Campbell JC. Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lidocaine/prilocaine cream (EMLA) for topical anaesthesia before vascular access. Br J Anaesth. 2009;102:210–215.
    1. Soltesz S, Dittrich K, Teschendorf P, Fuss I, Molter G. Topical anesthesia before vascular access in children. Comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaine-prilocaine patch. Anaesthesist. 2010;59:519–523.
    1. Masud S, Wasnich RD, Ruckle JL, Garland WT, Halpern SW, Mee-Lee D, et al. Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. J Pain Symptom Manage. 2010;40:510–519.
    1. Houck CS, Sethna NF. Transdermal analgesia with local anesthetics in children: review, update and future directions. Expert Rev Neurother. 2005;5:625–634.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren